{
    "title": "Gilead to buy 49.9% stake in cancer drug developer for $275 mln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8451295/Gilead-buy-49-9-stake-cancer-drug-developer-Pionyr-275-mln.html",
    "date": "2020-06-23",
    "keywords": [
        "drug",
        "cancer",
        "inc",
        "portfolio",
        "remdesivir",
        "option",
        "exercise",
        "deal",
        "gilead",
        "tuesday",
        "stake",
        "pionyr",
        "access",
        "drugmaker",
        "use",
        "covid19",
        "right",
        "rest",
        "developer",
        "fee",
        "pionyrs",
        "immunooncology",
        "py314",
        "py159",
        "food",
        "administration",
        "quarter",
        "span",
        "oncology",
        "analyst",
        "michael",
        "client",
        "note",
        "march",
        "company",
        "forty",
        "treatment",
        "blood",
        "pact",
        "month",
        "arcus",
        "market",
        "way",
        "value",
        "acquisition",
        "yee",
        "milestone",
        "forefront",
        "fight",
        "virus",
        "recovery",
        "trial",
        "skepticism",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}